Liberia says U.S. authorities allow use of experimental Ebola drug

MONROVIA/DAKAR, (Reuters) – U.S. authorities have approved a request from Liberia’s government to send sample doses of the experimental ZMapp drug to treat Liberian doctors infected with Ebola, the Liberian presidency said.

A statement on the Liberian presidency’s website said the drug would be delivered to the West African country this week by a U.S. government representative.

However, a representative for the U.S. Health and Human Services (HHS) Department said U.S. authorities had simply assisted in connecting the Liberian government with the drug’s manufacturer.

Around the Web

Comments